Search

Displaying results 6581 - 6590 of 10000 in total
  1. Drug

    Ixazomib

    go.drugbank.com/drugs/DB09570
    ApprovedInvestigational

    Ixazomib is a reversible proteasome inhibitor. Because it is a modified peptide boronic acid with one chiral center,[A264329] it is considered a boronate proteasome inhibitor. … [L51244] It was also investigated in other hematological malignancies as well as other conditions, such as systemic light chain (AL) amyloidosis, graft-versus-host disease, and lupus nephritis.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
  2. Drug

    Ferroheme

    go.drugbank.com/drugs/DB18267
    Investigational

    Categories: Heterocyclic Compounds with 4 or More Rings
  3. Drug

    Deltamethrin

    go.drugbank.com/drugs/DB13600
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Ferulic acid

    go.drugbank.com/drugs/DB07767
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Reviparin

    go.drugbank.com/drugs/DB09259
    Approved

    Reviparin is a low molecular weight heparin which seems to have a better safety profile than unfractionated heparin. … Reviparin has a molecular weight of 3.9 kDa.[A32021] It was developed by Abbott laboratories and in 2009, reviparin presented an orphan drug designation by the FDA.[L1469]

    Products: CLIVARIN 5726 IE A XA/ML, CLIVARODI 17178 A XA/ML
  6. Drug

    Heme arginate

    go.drugbank.com/drugs/DB17310
    Investigational

    Categories: Heterocyclic Compounds with 4 or More Rings
  7. Drug

    Drotebanol

    go.drugbank.com/drugs/DB01547
    ExperimentalIllicit

    Categories: Heterocyclic Compounds with 4 or More Rings
  8. Drug

    Daunorubicin

    go.drugbank.com/drugs/DB00694
    ApprovedInvestigational

    A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexSynonyms: (8S-cis)-8-acetyl-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione
  9. Drug

    Chromic citrate

    go.drugbank.com/drugs/DB14526
    Experimental

  10. Drug

    Otilonium

    go.drugbank.com/drugs/DB13500
    Investigational

    Categories: Drugs for Functional Gastrointestinal Disorders